Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
To evaluate safety and efficacy of pramipexole in the treatment of patients suffering from
moderate to severe RLS over 6 weeks under double blinded conditions followed by a 46 week
open label or double blind extension.